Recomendaciones del Grupo Español de Trabajo en Enfermedad de Crohn y Colitis Ulcerosa (GETECCU) sobre el tratamiento de pacientes con espondiloartritis asociada a enfermedad inflamatoria intestinal
Y. González-Lama , J. Sanz , G. Bastida , J. Campos , R. Ferreiro , B. Joven , A. Gutiérrez , X. Juanola , B. Sicilia , R. Veroz , J.P. Gisbert , M. Chaparro , E. Domènech , M. Esteve , F. Gomollón
{"title":"Recomendaciones del Grupo Español de Trabajo en Enfermedad de Crohn y Colitis Ulcerosa (GETECCU) sobre el tratamiento de pacientes con espondiloartritis asociada a enfermedad inflamatoria intestinal","authors":"Y. González-Lama , J. Sanz , G. Bastida , J. Campos , R. Ferreiro , B. Joven , A. Gutiérrez , X. Juanola , B. Sicilia , R. Veroz , J.P. Gisbert , M. Chaparro , E. Domènech , M. Esteve , F. Gomollón","doi":"10.1016/j.eii.2016.09.002","DOIUrl":null,"url":null,"abstract":"<div><p>Extraintestinal manifestations, particularly arthropaties, are a frequent problem in patients with inflammatory bowel disease. The relationship between those 2<!--> <!-->entities is close and data suggest that the bowel plays and important role in etiopathogenesis of spondyloarthritis. Association of inflammatory bowel disease with any kind of spondyloarthritis represents a challenging clinical scenario. It is necessary that both gastroenterologists and rheumatologists work together and have a fluent communication that may help the patient to receive the most appropriate treatment for each single situation. The aim of this review is to make some recommendations about the treatment of patients with inflammatory bowel disease and associated spondyloarthritis, in each single different clinical scenario.</p></div>","PeriodicalId":100473,"journal":{"name":"Enfermedad Inflamatoria Intestinal al Día","volume":"16 1","pages":"Pages 1-14"},"PeriodicalIF":0.0000,"publicationDate":"2017-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1016/j.eii.2016.09.002","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Enfermedad Inflamatoria Intestinal al Día","FirstCategoryId":"1085","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S1696780116300690","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0
Abstract
Extraintestinal manifestations, particularly arthropaties, are a frequent problem in patients with inflammatory bowel disease. The relationship between those 2 entities is close and data suggest that the bowel plays and important role in etiopathogenesis of spondyloarthritis. Association of inflammatory bowel disease with any kind of spondyloarthritis represents a challenging clinical scenario. It is necessary that both gastroenterologists and rheumatologists work together and have a fluent communication that may help the patient to receive the most appropriate treatment for each single situation. The aim of this review is to make some recommendations about the treatment of patients with inflammatory bowel disease and associated spondyloarthritis, in each single different clinical scenario.